Kane Biotech Inc Ord (KNBIF) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

We can hear you, Ray. Yeah, I think I've started the meeting. So just hang on. I need to, I've made you the organizer, Mark. So how do we, you know how to stop it at your side? Well, it doesn't matter if the meeting is started. Does it? We're five minutes early. Yeah. Don't say anything incriminating. We can just wait for five minutes before we start. Yeah. It states that the bottom of this session is being recorded. Yeah. So somehow I've lost John in my viewing here, but that's okay. I'll deal with that internally. There we go. There he is. I muted myself when I inadvertently turned the camera off, too. Got it. Oh. Five o'clock, Rob. Might as well kick it off. Okay. Good afternoon and good evening. This is the annual special meeting of the shareholders of Kane Biotech Incorporated. The meeting will now come to order. My name is Dr. Robert Heisinger, chair of the corporation. As this is the annual and special meeting of the shareholders that came Biotech Incorporated and pursuant to the bylaws of the corporation, I will act as chair of the meeting and Ray DuPuis will act as secretary of the meeting. I appoint Christine Calesso of TSX Trust Company as scrutinyer. The notice calling this meeting of shareholders was mailed to all the shareholders of record on April 12th, 2024. The secretary will annex the declaration as to such mailing to the minutes of the meeting. Will the scrutineer please submit the report on attendance? The scrutineer's report is as follows. We are pleased to report that there are 28 shareholders holding 60,826,838 common shares represented in person or by proxy at this meeting. This represents 46.14% of the 131,844,567 issued and outstanding common shares. I hereby adopt the scrutineer's report. Notice having been mailed in accordance with the byl...